Secondary Outcome(s)
|
Functional gain as measured by the DASH self questionnaire
[Time Frame: Day 12]
|
Functional gain as measured by the DASH self questionnaire
[Time Frame: Day 5]
|
Change in visual analog scale for pain
[Time Frame: Day 19 versus baseline]
|
Change in visual analog scale for pain
[Time Frame: Day 90 versus baseline]
|
FI2S score
[Time Frame: Day 19]
|
Functional gain as measured by the DASH self questionnaire
[Time Frame: Day 90]
|
Change in visual analog scale for pain
[Time Frame: Day 12 versus baseline]
|
FI2S score
[Time Frame: Day 12]
|
Functional gain as measured by the DASH self questionnaire
[Time Frame: Day 19]
|
Scapulohumeral amplitude gain in 3 main directions
[Time Frame: Day 90]
|
Change in visual analog scale for pain
[Time Frame: Day 5 versus baseline]
|
FI2S score
[Time Frame: Day 1]
|
FI2S score
[Time Frame: Day 5]
|
Functional gain as measured by the DASH self questionnaire
[Time Frame: Day 1]
|
Change in visual analog scale for pain
[Time Frame: Day 1 versus baseline]
|
FI2S score
[Time Frame: Day 26]
|
Functional gain as measured by the DASH self questionnaire
[Time Frame: Day 26]
|
Scapulohumeral amplitude gain in 3 main directions
[Time Frame: Day 26]
|
SF36 self questionnaire
[Time Frame: Day 90]
|
SF36 self questionnaire
[Time Frame: Day 1]
|
Change in visual analog scale for pain
[Time Frame: Day 26 versus baseline]
|
Scapulohumeral amplitude gain in 3 main directions
[Time Frame: Day 1]
|
SF36 self questionnaire
[Time Frame: Day 26]
|